Mitrix Bio
PrivateLast Round
Seed
Jul 1, 2021
Total Funding Raised
$250,000
Company Overview
Mitrix Bio operates in Healthcare & Life Sciences and is based in Pleasanton, California. Its latest recorded funding round was a Seed round in July 2021.
Mitrix Bio is a biotechnology company developing bioreactor-grown mitochondrial transplantation therapies to address age-related diseases and cellular dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitrix Bio Comparables
Compare Mitrix Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoSense, Inc. | 87% | |
| Cellergy Therapeutics | 82% | |
| PAEAN Biotechnology | 79% |
For institutional investors. Book with your work email.
Mitrix Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2021 | ||||
| Pre Seed | Jan 28, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mitrix Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arben Ventures | Seed |
| Longevitytech.fund | Pre Seed |
| R42 Group | Pre Seed |
| quadraScope Ventures | Seed |
| Methuselah Foundation | Seed |
| Lauder Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2026
Monthly visitors increased 51% MoM, reaching 3.2K.
- Jun 1, 2025
Monthly visitors increased 47% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Mitrix Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mitrix Bio's valuation, stock price, and market status.
Is Mitrix Bio a public or private company?
Mitrix Bio is a private company.
What is the current stock price of Mitrix Bio?
Mitrix Bio is a private company, so its shares have no public market price. Caplight tracks Mitrix Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mitrix Bio worth (valuation)?
Valuation information for Mitrix Bio is not publicly available.
Can I buy Mitrix Bio stock?
Mitrix Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mitrix Bio's last funding round?
Mitrix Bio's most recent funding round was Seed on July 1, 2021.
Who are the main investors in Mitrix Bio?
Key investors in Mitrix Bio include Arben Ventures, Longevitytech.fund, R42 Group, quadraScope Ventures, Methuselah Foundation.
Will Mitrix Bio IPO soon?
No public IPO plans have been announced for Mitrix Bio.
How can I track Mitrix Bio secondary market activity?
Caplight tracks bids, offers, and trades in Mitrix Bio's shares on secondary markets.